These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37102347)

  • 1. [Proposal for a diagnostic and therapeutic care pathway of the Piedmont Region on lipid-lowering and antithrombotic treatment in patients with peripheral arterial disease].
    Patti G; Varbella F; Gaggiano A; Mennuni M; Annibali G; Celentani D; Del Nevo F; Piazza S; Musumeci G
    G Ital Cardiol (Rome); 2023 May; 24(5):344-354. PubMed ID: 37102347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic Therapy for Peripheral Artery Disease: Recent Advances.
    Hussain MA; Al-Omran M; Creager MA; Anand SS; Verma S; Bhatt DL
    J Am Coll Cardiol; 2018 May; 71(21):2450-2467. PubMed ID: 29793635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editor's Choice - Optimal Pharmacological Treatment of Symptomatic Peripheral Arterial Occlusive Disease and Evidence of Female Patient Disadvantage: An Analysis of Health Insurance Claims Data.
    Peters F; Kreutzburg T; Rieß HC; Heidemann F; Marschall U; L'Hoest H; Debus ES; Sedrakyan A; Behrendt CA
    Eur J Vasc Endovasc Surg; 2020 Sep; 60(3):421-429. PubMed ID: 32669223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic treatment in peripheral artery disease.
    Olinic DM; Tataru DA; Homorodean C; Spinu M; Olinic M
    Vasa; 2018 Feb; 47(2):99-108. PubMed ID: 29160765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy.
    Aboyans V; Bauersachs R; Mazzolai L; Brodmann M; Palomares JFR; Debus S; Collet JP; Drexel H; Espinola-Klein C; Lewis BS; Roffi M; Sibbing D; Sillesen H; Stabile E; Schlager O; De Carlo M
    Eur Heart J; 2021 Oct; 42(39):4013-4024. PubMed ID: 34279602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy in peripheral artery disease.
    Foley TR; Waldo SW; Armstrong EJ
    Vasc Med; 2016 Apr; 21(2):156-69. PubMed ID: 26823456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral arterial disease and limb salvage: a new arena for the cardiologist.
    Lewis BS; Atar D
    Eur Heart J Cardiovasc Pharmacother; 2018 Jul; 4(3):136-137. PubMed ID: 30052851
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipid-lowering treatment in peripheral artery disease.
    Katsiki N; Giannoukas AD; Athyros VG; Mikhailidis DP
    Curr Opin Pharmacol; 2018 Apr; 39():19-26. PubMed ID: 29413998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?
    van Peet PG; Gussekloo J; den Elzen WP; Blom JW; de Waal MW; de Ruijter W
    Scand J Prim Health Care; 2015; 33(4):260-8. PubMed ID: 26683286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial.
    Qamar A; Morrow DA; Creager MA; Scirica BM; Olin JW; Beckman JA; Murphy SA; Bonaca MP
    Vasc Med; 2020 Apr; 25(2):124-132. PubMed ID: 32000630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic Therapy in Peripheral Artery Disease: Generating and Translating Evidence Into Practice.
    Jones WS; Patel MR
    J Am Coll Cardiol; 2018 Jan; 71(3):352-362. PubMed ID: 29348028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic Therapy for Peripheral Artery Disease in 2018.
    Hess CN; Hiatt WR
    JAMA; 2018 Jun; 319(22):2329-2330. PubMed ID: 29860284
    [No Abstract]   [Full Text] [Related]  

  • 13. Tackling Elevated Risk in PAD: Focus on Antithrombotic and Lipid Therapy for PAD.
    Govsyeyev N; Nehler MR; Hiatt WR; Bonaca MP
    Curr Cardiol Rep; 2020 Jan; 22(3):13. PubMed ID: 31997026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel antithrombotic regimen in patients with ischemic heart disease and peripheral arterial disease: can we identify those who derive the highest benefit?
    Mahtta D; Virani SS
    J Med Econ; 2020 Jul; 23(7):670-672. PubMed ID: 32267794
    [No Abstract]   [Full Text] [Related]  

  • 15. A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative.
    Hess CN; Norgren L; Ansel GM; Capell WH; Fletcher JP; Fowkes FGR; Gottsäter A; Hitos K; Jaff MR; Nordanstig J; Hiatt WR
    Circulation; 2017 Jun; 135(25):2534-2555. PubMed ID: 28630267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland.
    Soini E; Virtanen O; Väätäinen S; Briere JB; Bowrin K; Millier A
    Adv Ther; 2020 Jul; 37(7):3348-3369. PubMed ID: 32519113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic strategies for patients with coronary and lower extremity peripheral artery diseases: a narrative review.
    De Luca L; Bonaca MP; Magnani G
    Expert Rev Cardiovasc Ther; 2020 Dec; 18(12):881-889. PubMed ID: 33021875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary Review of Antithrombotic Therapy in Peripheral Artery Disease.
    Hess CN; Bonaca MP
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009584. PubMed ID: 33023325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antithrombotic therapy in patients with peripheral artery diseases].
    Svetlikov AV; Sapelkin SV; Ishpulaeva LÉ; Gorbunov GN
    Angiol Sosud Khir; 2018; 24(3):13-17. PubMed ID: 30321141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic Therapy in Lower Extremity Artery Disease.
    Vrsalovic M; Aboyans V
    Curr Vasc Pharmacol; 2020; 18(3):215-222. PubMed ID: 30727898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.